Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis
Palbociclib is a specific CDK4/6 inhibitor that has been widely applied in multiple types of tumors. Different from cytotoxic drugs, the anticancer mechanism of palbociclib mainly depends on cell cycle inhibition. Therefore, the resistance mechanism is different. For clinical cancer patients, drug r...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-01-01
|
| Series: | Frontiers in Molecular Biosciences |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1116398/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|